IP Library Granted Patent US 9,958,516
Granted Patent B2
US 9,958,516 · App. 14/226,572 · Granted May 1, 2018

Biological detector and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,958,516
App. No.
14/226,572
Granted
May 1, 2018
Kind
B2
Abstract

A biological detector includes a conduit for receiving a fluid containing one or more magnetic nanoparticle-labeled, biological objects to be detected and one or more permanent magnets or electromagnet for establishing a low magnetic field in which the conduit is disposed. A microcoil is disposed proximate the conduit for energization at a frequency that permits detection by NMR spectroscopy of whether the one or more magnetically-labeled biological objects is/are present in the fluid.

Claims (15)

1. A method for detecting a target analyte in a sample, the method comprising:

introducing magnetic particles comprising target-specific moieties to a sample comprising a plurality of target analytes under conditions such that at least one cluster of magnetic particles and target analytes is formed; and

using a nuclear magnetic resonance (NMR) device in order to measure a signal due to a change in relaxation rate, wherein the relaxation rate changes in the presence of the at least one cluster, thereby detecting the target analyte in the sample.

2. The method according to claim 1 , wherein measuring is accomplished in the presence of other components in the sample.

3. The method of claim 1 , wherein the changes are selected from relaxation times T1, T2, T2*, or a combination thereof.

4. The method according to claim 1 , wherein the NMR devices comprises:

a magnet configured to produce a magnetic field;

a vessel configured to hold the sample and being located within the magnetic field;

a radio frequency (RF) coil located within the magnetic field.

5. The method according to claim 4 , wherein the RF coil wraps around the vessel.

6. The method according to claim 4 , wherein the magnetic is a permanent magnet.

7. The method according to claim 1 , wherein the target-specific moieties are antibodies.

8. The method according to claim 1 , wherein the sample is a biological sample.

9. The method according to claim 8 , wherein the biological sample is blood or urine.

10. The method according to claim 1 , wherein the magnetic particles are superparamagnetic particles.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2015
From: ALAM, TODD M.
To: SANDIA CORPORATION
Reel/Frame 036264/0798 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2014
From: SILLERUD, LAUREL
To: THE REGENTS OF THE UNIVERSITY OF NEW MEXICO
Reel/Frame 033126/0300 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2014
From: THE REGENTS OF THE UNIVERSITY OF NEW MEXICO
To: STC.UNM
Reel/Frame 033126/0324 →